12 Property, plant and equipment
 
Total
Land and buildings
Plant and
machinery
Other
equip-
ment
Under construc-
tion
Not used
for operating
activities
Balance at 1 January 2006
 
 
 
 
 
 
Cost
8,804
1,664
6,483
284
343
30
Depreciation and impairment losses
5,054
649
4,098
252
37
18
Carrying amount
3,750
1,015
2,385
32
306
12
 
 
 
 
 
 
 
Changes in carrying amount:
 
 
 
 
 
 
- Capital expenditure
418
16
80
4
318
-
- Put into operation
-
24
158
13
(195)
-
- Acquisitions
14
3
11
-
-
-
- Disposals
(6)
(2)
(4)
-
-
-
- Depreciation
(400)
(54)
(336)
(10)
-
-
- Impairment losses
(12)
(1)
(9)
-
(2)
-
- Change in estimate of decommisioning costs
17
-
17
-
-
-
- Exchange differences
(104)
(27)
(60)
(1)
(16)
-
- Reclassifications
(23)
(17)
1
-
(7)
-
- Other changes
1
1
-
-
-
-
 
(95)
(57)
(142)
6
98
-
 
 
 
 
 
 
 
Balance at 31 December 2006
 
 
 
 
 
 
Cost
8,578
1,603
6,286
242
428
19
Depreciation and impairment losses
4,923
645
4,043
204
24
7
Carrying amount
3,655
958
2,243
38
404
12
 
 
 
 
 
 
 
Changes in carrying amount:
 
 
 
 
 
 
- Capital expenditure
427
4
34
3
386
-
- Put into operation
-
49
208
13
(270)
-
- Acquisitions
37
17
19
-
1
-
- Disposals
(38)
(15)
(23)
-
-
-
- Depreciation
(373)
(56)
(307)
(10)
-
-
- Impairment losses
(152)
(1)
(150)
-
(1)
-
- Change in estimate of decommisioning costs
5
-
5
-
-
-
- Exchange differences
(99)
(28)
(52)
-
(19)
-
- Reclassifications
(21)
14
(12)
(1)
(22)
-
- Other changes
(1)
(1)
2
-
(1)
(1)
 
(215)
(17)
(276)
5
74
(1)
Balance at 31 December 2007
 
 
 
 
 
 
Cost
8,688
1,634
6,309
246
481
18
Depreciation and impairment losses
5,248
693
4,342
203
3
7
Carrying amount
3,440
941
1,967
43
478
11
Property, plant and equipment includes assets acquired under finance lease agreements with a carrying amount of €17 million (31 December 2006: €27 million). The related commitments are included under Borrowings and amount to €8 million (31 December 2006: €11 million). The total of the minimum lease payments at the balance sheet date amounts to €10 million (31 December 2006: €11 million) and their present values to €9 million (31 December 2006: €10 million).
Overview of minimum lease payments in time:
2008
2
2009-2012
7
After 2012
1
 
 
Total
10
In 2007, €152 million in impairment losses was recognized (2006: €12 million). In 2007 the asset impairment losses mainly related to DSM Anti-Infectives (€146 million).
The impairment losses on Property, plant and equipment in 2006 amounted to €12 million and mainly related to the termination of the aspartame business (€2 million), the closing of the production facilities in Landskrona in Sweden (€1 million) and the restructuring of the Geleen (Netherlands) and Linz (Austria) sites of DSM Pharmaceutical Products (€9 million).